Centre asks States, U.T.s to step up Ebola surveillance

2. Why in the News

3. Background & Evolution

4. Core Static Facts

Item Detail
Nodal Indian body Ministry of Health & Family Welfare (MoHFW); operational arm — National Centre for Disease Control (NCDC) [S2]
Surveillance mechanism Integrated Disease Surveillance Programme (IDSP), since 2004, covers 33+ epidemic-prone diseases across 36 States/UTs [S2]
Key official (2026 advisory) Union Health Secretary Punya Salila Srivastava [S6]
Union Health Minister J.P. Nadda — reviewed national preparedness [S5]
International trigger body World Health Organization (WHO), via PHEIC declaration under IHR (2005) [S1]
Virus strain Bundibugyo ebolavirus (BVD) [S1]
Affected countries DRC (outbreak epicentre), Uganda; high-risk neighbour flagged: South Sudan [S1][S6]
Case fatality rate (BVD historically) 30–50% [S1]
Cases (as of 1 July 2026) DRC: 1,460 confirmed, 452 deaths; Uganda: 20 confirmed, 2 deaths + 1 probable death [S1]
Exported case France, 24 June 2026 (returning doctor) [S1]
Symptoms flagged by India's advisory Fever, weakness, muscle pain, headache, sore throat, vomiting, diarrhoea, stomach pain, rash, red eyes [S6]

5. Multi-Dimensional Analysis

Public Health / Administrative - Tests India's federal health surveillance architecture — Centre issues advisories, but implementation (hospital infection control, RRTs) rests with States/UTs, an examinable Centre-State dynamic [S6][S2]. - Reinforces role of point-of-entry surveillance (airports/ports) given "growing international trade and travel," as noted by the Health Secretary [S6].

Geopolitical / Strategic - Demonstrates WHO's PHEIC mechanism as a global early-warning trigger obligating member states (including India) to enhance preparedness under the IHR (2005) framework [S1]. - Highlights risk transmission pathways via neighbouring/bordering states (South Sudan flagged), relevant to India's own porous-border health risk assessments [S6].

Social - Preparedness messaging targets vulnerable exposure groups — travellers, healthcare workers — echoing lessons from COVID-19 on early clinical triage and isolation protocols [S6].

Scientific/Technological - Absence of a licensed vaccine/treatment for Bundibugyo virus disease underscores R&D gaps versus Zaire ebolavirus (for which vaccines like Ervebo exist) [S1].

Ethical/Governance - Raises the transparency question of timely case reporting and coordination between State health departments and NCDC/IDSP nodal officers.

6. Recent Developments (last 12-18 months)

7. Prelims Hooks

8. Mains Relevance

9. Related Topics to Study Next

10. Common Errors / Trap Areas

11. Sources